advanced search

DIANT Pharma

DIANT Pharma develops proprietary continuous manufacturing technology, including its scalable jet technology, for nanoparticles with a wide array of applications throughout multiple industries, such as lipid nanoparticles (LNPs) and liposomes for pharmaceutical formulations.


Visit Website

Headquarters
DIANT Pharma Inc
1392 Storrs Road
Unit 4213 Room 108
Storrs, CT 06269-4213
United States

DIANT Pharma develops proprietary continuous manufacturing technology for nanoparticles with a wide array of applications throughout multiple industries., including lipid nanoparticles (LNPs) and liposomes for pharmaceutical formulations.

The DIANT series systems use state-of-the art nanoparticle processing technology, including a scalable jet that makes nanoparticle generation simple from R&D to production. DIANT Pharma seeks partners to broaden the use of its technology.

With roots in the University of Connecticut  (CT, US), the company is privately held and was founded in 2019.

Authors and Contacts

Dr Antonio Costa
Chief Executive Officer
DIANT Pharma

Article

EARLY INSIGHT
Dr Antonio Costa
ENHANCED PROCESS CONTROL FOR LIPID-BASED NANOPARTICLES: LNPS AND LIPOSOMES
Antonio Costa discusses the use of lipid nanoparticles in the modern drug delivery industry and introduces the DIANT system for the continuous processing of nanoparticles with integrated process analytical technology, which can provide the quality required for these injectable, complex formulations.
Top